MSB 2.51% 97.0¢ mesoblast limited

MSB - Misleading information investigation, page-3

  1. 177 Posts.
    lightbulb Created with Sketch. 21
    This is the 4th thread this rubbish has been given. Seriously, STOP!

    Shame for them that the advisory committee decision ended up going 9 to 1 in favour of MSB, so how exactly did management mislead investors on efficacy? Someone just lost money on the drop after the FDA meeting notes and cried wolf..

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.